Poking CD40 for cancer therapy, another example of the Goldilocks effect

 Abstract

Commentary to: Immune modulation with weekly dosing of an agonist CD40 antibody in a Phase I study of patients with advanced solid tumors Jens Rüter, Scott J. Antonia, Howard A. Burris, Richard D. Huhn and Robert H. Vonderheide

Full Text Options
Article
Metrics
 Share
 Info
Pages
994 - 996
doi
10.4161/cbt.10.10.13976
Type
Commentary
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Poking CD40 for cancer therapy, another example of the Goldilocks effect